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Abstract
One of the key components of the innate immune response is the recognition of microbial products
such as LPS by Toll-like receptors on monocytes and neutrophils. We show here that short-term
stimulation of primary human monocytes with LPS led to an increase in adhesion of monocytes to
endothelial cells and a dramatic decrease in transendothelial migration under static conditions. In
contrast, under normal physiological flow, monocyte adhesion and migration across a human
umbilical vein endothelial cell monolayer appeared to be unaffected by LPS treatment. LPS
stimulation of monocytes activated b1 and b2 integrins, but did not increase their surface expression
levels. During septic shock, reduction in blood flow as a result of vasodilation and vascular
permeability leads to adhesion and accumulation of LPS-stimulated circulating monocytes onto the
blood vessel walls. The different findings of monocyte migration under static and flow conditions in
our study may offer one explanation for this phenomenon. The rapid engagement of LPS-activated
monocytes preventing transendothelial migration could represent a novel mechanism of bacterial
exclusion from the vasculature. This occurs during the early stages of sepsis, and in turn may
modulate the severity of the pathophysiology.
Introduction
At sites of inflammation, signals derived from the underlying
tissue induce localized changes in the adhesive properties
of the endothelium. Leukocytes are then able to adhere to
the endothelium and extravasate in large numbers to the in-
flammatory lesion. This process has been described as
a multi-step adhesion cascade (1–3). The change in the ad-
hesive properties of the endothelium is brought about by
the up-regulation of adhesion molecules on the endothelium
and this represents a critical early step in the recruitment of
leukocytes to sites of inflammation (4). Acute inflammatory
processes are characterized by the early infiltration of neu-
trophils and monocytes, while the chronic inflammatory
phase is associated with the recruitment of monocytes and
effector memory T cells (5). While a great deal of progress
has been made in understanding the molecular events oc-
curring during each step of the adhesion cascade, it
remains to be clarified how a tightly adhered leukocyte can
‘de-adhere’ and go on to cross the endothelium. Clearly,
a fine balance must exist between adhesion and release,
which serves to drive migration of the leukocyte through the
endothelium. During a localized infection, however, the in-
vading micro-organism may breach the vascular barrier and
occupy the blood compartment, directly activating circulat-
ing leukocytes via pathogen-associated molecular patterns
(PAMPs). LPS is a PAMP that constitute a major component
of the outer membrane of gram-negative bacteria. It is
a complex glycolipid composed of a hydrophilic polysac-
charide and a hydrophobic domain, known as lipid A (6).
LPS forms a complex with LPS-binding protein and can sig-
nal through membrane-bound CD14 on monocytes and my-
eloid cells (7). The LPS signal is transmitted across the cell
membrane via a co-receptor, Toll-like receptor (TLR)-4 (8).
Severe sepsis is a major cause of death among patients in
intensive care units (9). The presence of LPS in blood can
set off a cascade of host responses that in extreme cases
can lead to sepsis (endotoxemia or blood poisoning). Under
normal homeostatic conditions, these responses serve to ac-
tivate the innate immune response and, ultimately, to clear
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the infection. However, if the host response is not tightly con-
trolled, an overwhelming systemic inflammatory response
ensues and can lead to a massive drop in blood pressure,
multiple organ failure and fatal septic shock. To understand
why endotoxemia leads to such a catastrophic syndrome, it
is important to consider the biological function of endotoxin.
LPS activates almost every component of the immune sys-
tem (10). Particularly, circulating monocytes can undergo
a rapid activation by LPS within the vasculature. Thus, at
the earliest stage of sepsis, monocytes can serve as sentinel
cells after a breach of the blood barrier by bacterial endo-
toxins. Such a massive stimulation of monocytes in the blood
also results in the production of pro-inflammatory mediators
at later stages, notably tumour necrosis factor-alpha (TNFa),
IL-1, IL-6 and IL-8. The combined action of these cytokines
is known to activate endothelium and leads to increased leu-
kocyte emigration and vascular permeability. This results in
leakage of plasma into the tissues and a drop in blood pres-
sure and flow (11, 12).
We have found that the presence of LPS during static trans-
migration assays had a profound effect on the ability of mono-
cytes to transmigrate across monolayers of human umbilical
vein endothelial cells (HUVECs). These observations promp-
ted us to compare the effects of LPS on monocyte migration
under static and flow conditions and to investigate a role for
LPS on monocytes during the early stages of septicaemia.
Methods
Reagents and antibodies
For flow cytometry analysis of human PBMCs and monocyte
purity, the following antibodies were used: anti-CD3, anti-
CD14 and anti-CD19 and CD62L directly conjugated to FITC
(PharMingen, San Diego, CA, USA). Immunostaining for
CXCR4 was performed using mAb 12G5 directly conjugated
to PE (R and D Systems, Abingdon, UK). For integrin stain-
ing, antibodies were purified from hybridoma supernatants
of cells grown in DMEM supplemented with the serum sub-
stitute Ultroser (PALL Life Sciences, New York, NY, USA).
Antibodies used were 9EG7 (rat anti-mouse b1 integrin,
IgG2a) which cross-reacts with human b1 (13), TS1/18
[mouse anti-human leukocyte function-associated antigen-1
(LFA-1), b2 chain, IgG1], TS1/22 (mouse anti-human LFA-1, aL
chain, IgG1) and MARK-1 (mouse anti-rat kappa L chain,
IgG1). For blocking studies, antibodies to b1 (PS2) and b2
integrins (TS1/18) were used. mAbs mAb24 and 15/7 were
kind gifts from Nancy Hogg and Elan Pharmaceutical Inc.
(San Francisco, CA, USA), respectively. Human stromal derived
factor-1 (SDF-1) was also kind gift from RMF Dictagene S.A.,
(Epalinges, Switzerland). LPS was derived from Escherichia
coli 055:B5 (3120-25-0; Difco, Detroit, MI, USA and Sigma).
Endothelial cells
HUVECs were isolated by collagenase treatment of umbilical
veins (14). HUVECs were maintained in M199 supplemented
with 20% FCS (PAA Laboratories, Linz, Austria), 25 mM
HEPES, non-essential amino acids, sodium pyruvate, endo-
thelial cell growth supplement (15 lg ml1; Upstate Biotech-
nology, New York, NY, USA) and heparin (4 lg ml1;
Sigma). Cells were used between passages 2 and 5.
Primary lymphocytes and monocytes
Human PBMCs were obtained from fresh blood of healthy
donors. Briefly, citrated blood was separated by Ficoll-
Paque Plus (Pharmacia Biotech, Uppsala, Sweden) gradient
centrifugation. For the purification of monocytes, blood
was collected from healthy donors into tubes containing
EDTA (7.5 mM) and incubated for 1 h at room temperature
before the addition of a one-tenth volume of 8% (w/v) Dex-
tran T500 (Pharmacia) in 0.9% NaCl. After 1 h, the plasma-
rich top layer was layered onto NycoPrep 1.068 (Axis-Shield,
Oslo, Norway) and centrifuged at 600 3 g for 30 min.
The monocyte-enriched fraction was collected and washed
in either flow assay or static adhesion assay buffer. Mono-
cyte preparations were typically 70–80% pure (CD14+
cells, determined by flow cytometry) with contaminating cells
comprised mostly of T-lymphocytes (CD3+). Monocytes used
for immunostaining with mAb 12G5 were purified from
citrated blood collected from healthy donors using a mono-
cyte isolation kit (Miltenyi Biotec, Bergisch Gladbach,
Germany).
Flow cytometry
Cells in suspension were collected, washed in M199/2%
FCS and then re-suspended in PBS containing 0.2% BSA
and 0.1% sodium azide (flow cytometry buffer) with saturat-
ing amounts of antibodies, either uncoupled or directly con-
jugated to FITC. After a 30-min incubation on ice, cells were
washed and analysed directly or incubated with streptavidin–
PE for biotinylated antibodies before analysis by flow cytom-
etry (FACScan; Becton Dickinson Co., Mountain View, CA,
USA). Control cell suspensions were incubated with second-
ary antibody alone.
LPS pre-treatment of leukocytes
Leukocyte suspensions were incubated with LPS (1 lg ml1)
for 15 min at 37C. The cells were then washed and re-
suspended in either flow or static adhesion assay buffer.
Pre-treatment of purified monocytes with functional blocking
antibodies to integrins
Blocking mAb to b1 (PS2) and/or b2 (TS1/18) were added to
purified monocytes added at a concentration of 20 lg ml1
for 20 min immediately prior to HUVEC co-culture under
flow. Isotype control mAb was added in the absence of the
relevant blocking antibody to ensure total antibody concen-
tration was maintained during the course of the flow assay.
Static transendothelial migration assay
HUVECs (6 3 104) were cultured on 10 mm diameter poly-
carbonate membranes (8 lm pore size, Life Technologies)
pre-coated with collagen (collagen G, Seromed, 100 lg
ml1 in HBSS) in M199 culture medium for 3–4 days. For ac-
tivation, HUVECs were pre-incubated with TNFa (500 U
ml1) for 4 h. The cultures were washed in M199 with 2%
FCS prior to the addition of the PBMCs. The chemokine
SDF-1 was added to the lower chamber at a final concentra-
tion of 100–200 ng ml1. Washed PBMCs (5 3 105–7 3 105
per insert) or purified monocytes (2–3 3 105 per insert) were
248 LPS regulates monocyte migration
added to each filter and incubated for 2 h at 37C. Cells
were collected from the lower (transmigrated) and upper
chamber (unadherent) and counted by light microscopy. In
studies using PBMCs, the cells were pooled from quadrupli-
cate wells and stained for CD3 and CD14 to determine the
percentage of T-cell and monocyte populations present in
each well.
Adhesion assays on HUVECs: FACS analysis of non-adherent
populations
HUVECs were grown to confluence in 3.5-cm tissue culture
dishes pre-coated with collagen (100 lg ml1) in HBSS as
described. The monolayers were rinsed and the PBMCs
added. The cultures were left for 1 h at 37C and non-
adherent cells were recovered.
Static adhesion assays on immobilized ICAM-1
Purified Intercellulor adhesion molecule-1 (ICAM-1) (15) was
directly coated onto 96-well plates at 10 lg ml1 in 50 ll
PBS for 1 h at room temperature. The wells were blocked
with 1% BSA for 1 h at room temperature and washed with
wash buffer (HBSS, Ca2+ 1.25 mM, Mg2+ 0.5 mM and 0.2%
BSA). Purified monocytes were pre-incubated with 1% hu-
man serum and either an anti-b2 antibody (TS1/18) or an iso-
type-matched control at 20 lg ml1 for 30 min at 37C. Cells
were plated in triplicate at 2.5 3 105 cells per well for 30 min
at 37C. Non-adherent monocytes were removed by wash-
ing and adherent cells fixed stained with 0.1% crystal violet
in 20% methanol for 10 min. The wells were washed and
allowed to air-dry before dissolving the stained fixed cells in
methanol and measuring the optical density at 570 nm. Data
presented are expressed as a mean of four wells 6 SEM.
Static adhesion assays on HUVECs: microscopic analysis
of adherent, migrated and non-migrated populations
HUVECs were cultured in pre-coated 24-well plates for 2–
3 days to establish confluent monolayers. Purified monocytes
(3 3 105 cells per well) were incubated for 60 min at 37C.
Non-adherent cells were removed by gentle washing of the
monolayers. Three separate fields were recorded for 2 min
each using time-lapse recording facilities. This time period
represents a minimum time to confirm transmigration by ob-
serving the cell kinetics of phase dark (transmigrated) cells
(16). Phase light cells were counted as non-transmigrated
cells that remained adherent on HUVEC surfaces. Transmi-
gration was calculated as the percentage of the sum of
phase light and phase dark cells and expressed as a mean
of three fields.
Flow assays
For flow assays, glass cover slips (22 3 50 mm) were pre-
pared by coating with 3-aminopropyltriethoxysilane (Sigma)
(17). Prior to culturing cells, the slides were sterilized with
ethanol and coated with 0.2% gelatine/4% FCS/HBSS.
HUVECs (7 3 105 per slide) were cultured until confluent
(2–3 days) before being attached to a cell adhesion flow
chamber (CAF10; Immunetics, Cambridge, MA, USA). Wash
buffer (M199, 0.15% BSA and 20 mM HEPES) or a suspension
of monocytes (2 3 106 cells ml1) was perfused over the
HUVEC monolayer at 0.05 Pa; representative of the shear
rates within small venules or capillaries. The flow chamber
was mounted on a heated microscope stage (37C) and
observations made using phase-contrast microscopy
recorded using time-lapse recording facilities. For the flow
assays, the HUVEC monolayer was treated for 4 h with TNFa
as described above, which was washed out prior to addition
of monocytes. The suspension of monocytes was perfused
over the activated HUVECs for 5 min followed by wash
buffer for 30 min. Monocytes adhered to the surface of the
HUVECs have a phase light appearance, whereas cells that
have transmigrated across the monolayer have a phase dark
appearance (18, 19). All experiments were carried out using
single-field analysis and at least three experiments were per-
formed. Results are presented as mean percentage of total
cells per field 6 SEM.
Flow assay at decreasing flow rates
A monocyte (2 3 106–3 3 106 cells ml1) suspension
was perfused over unactivated HUVECs cultured on slides
as described above for 5 min at a flow rate of 0.05 Pa.
Adherent cells were counted in three separate fields and
represented as a mean total 6 SEM. The flow was then
reduced to a fixed lower rate for 2 min before adherent
cells were counted again in three separate fields. This
procedure was repeated for consecutive reductions in flow
rate. Flow was then resumed at 0.05 Pa for 1 h before trans-
migration was assessed by time-lapse recording of a single
field for 2 min. Transmigration was represented as a mean
percentage (6SEM) of three separate fields at specific
time points.
Controlled detachment assay
The controlled detachment assay was performed as previ-
ously described (20). Briefly, a monocyte (2 3 106–3 3 106
cells ml1) suspension was perfused over unactivated
HUVECs cultured on slides as described above for 5 min at
a flow rate of 0.05 Pa. The flow was stopped for 10 min to in-
troduce a period of stasis. The flow was resumed at the
same flow rate for 1 min and adherent cells in three separate
fields counted. This was repeated using incremental higher
wall shear stresses. Results were described as the total
number of cells adhered per static field to the cultured
HUVEC monolayer for each shear stress. Experimental data
were represented as a mean with standard deviation of the
counts done in the three fields. Flow was then resumed at
0.05 Pa for 1 h before transmigration was assessed by time-
lapse recording of a single field for 2 min. Transmigration
was represented as a mean percentage (6SEM) of three
separate fields at specified time points.
Results
During a series of transmigration assays, we observed that
LPS from E. coli consistently reduced transmigration of
monocytes across endothelial monolayers. This effect was
almost immediate as it occurred within 15 min. It has been
reported that LPS can activate the endothelium over a period
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of several hours and thereby increase monocyte transmigra-
tion. In order to explain our contradictory findings, we inves-
tigated whether there is a direct primary short-term
inhibitory effect of LPS on primary monocytes.
LPS pre-treatment of monocytes selectively inhibits
transendothelial migration
We performed transmigration studies using PBMCs pre-trea-
ted with or without LPS for 15 min across unactivated
HUVECs using the CXCR4 ligand SDF-1, a chemokine that
can mediate leukocyte adhesion and transmigration (21).
We have established that surface expression levels of the
chemokine receptor CXCR4 on monocytes after stimulation
with LPS for 15 min remained unchanged (Fig. 1a). This is
consistent with a previous study showing down-regulation of
CXCR4 only after overnight incubation with LPS (22). Trans-
migrated cells to SDF-1 were collected from the lower cham-
bers and identified as monocytes or lymphocytes by flow
cytometry (data not shown). Pre-treatment of PBMCs with
LPS reduced the number of transmigrated monocytes, but
not T-lymphocytes, which do not have receptors for LPS
(Fig. 1b). The inclusion of polymyxin B, a molecule that
sequesters and neutralizes LPS, abrogated this effect (data
not shown) (23, 24). Since excess LPS was removed by
washing the monocytes prior to use, LPS must have an irre-
versible effect on monocyte function. Delaying the addition
of LPS-pre-treated monocytes to the endothelial monolayers
for 2 h did not abrogate this effect (data not shown). There-
fore reduced transmigration was not due to a carry-over of
LPS by the monocytes to the endothelium. A dose response
was carried out and showed that pre-treatment with LPS at
a concentration of 1 lg ml1 gave optimal inhibition of
monocyte migration across unactivated HUVECs (data not
shown). Based on this, we used LPS at 1 lg ml1 throughout
this study. In human serum, an equivalent amount of LPS
(ranging from 0.05 to 2.08 lg ml1) would create a life-
threatening septic shock (25, 26).
The adhesion of monocytes to HUVECs is altered following
pre-incubation with LPS
The inhibition of monocyte transmigration suggested that the
effect might be due to changes in the adhesive properties of
the monocytes. Indeed, LPS is known to induce monocyte
adhesion (27) and cell spreading of macrophages (28).
Transmigration depends on an adhesive step but the cell
must then be able to de-adhere in order to cross the endo-
thelium. It was therefore possible that, upon treatment with
LPS, the monocytes had become too adhesive and could
no longer detach from the HUVECs. To test this hypothesis,
confluent monolayers of unstimulated HUVECs were incu-
bated with PBMCs, which had been pre-treated with LPS.
Non-adherent cells were subsequently harvested and ana-
lysed by flow cytometry for leukocyte sub-populations. This
demonstrated a reduction in the number of monocytes but
no effect was seen with T cells (Fig. 1c and d). This showed
that LPS pre-treatment induced a change in the adhesive
properties of monocytes, and this may be linked to their in-
ability to migrate across endothelium.
LPS pre-treatment of monocytes increases adhesion to
HUVECs but inhibits monocyte transmigration
To exclude an indirect effect of LPS, monocytes were puri-
fied from PBMCs populations. They also showed increased
adhesion and reduced transmigration to SDF-1 after LPS
pre-treatment (Fig. 2a). So far, we have investigated the role
of LPS-activated monocytes on non-inflammatory endothe-
lium. In vivo, however, the endothelium would be exposed
to LPS resulting in inflammatory activation. As part of this
study, we employed adhesion assays to address the latter
phase of sepsis, specifically where endothelial cells have
been exposed to a battery of inflammatory agents for pro-
longed periods. Previous reports have shown that activating
endothelium with LPS induced expression of ICAM-1 and
vascular cell adhesion molecule-1 (VCAM-1) and increased
adhesion of mononuclear cells (29–33). However, stimulating
HUVECs with TNFa was considered to be more representa-
tive of an in vivo scenario where the endothelium would not
just be exposed to LPS in the vascular compartment, but
a milieu of stronger inflammatory stimulants that promote
transmigration released by adherent or recruited monocytes.
This led us to investigate interactions of LPS-pre-treated
monocytes with fully activated endothelium. Surprisingly,
similar levels of increased adhesion were seen with acti-
vated and unactivated endothelium (Fig. 2a). Similarly, LPS
pre-treated monocytes transmigrated less efficiently through
activated and unactivated endothelium than non-treated
monocytes. Thus, reduced transmigration is due to a process
regulated by the monocytes and not by the vascular endo-
thelium. However, the intriguing observation was that the ma-
jority of the monocytes remained firmly attached to the
endothelial monolayer (Fig. 2b).
To study how LPS may affect monocyte positioning in the
endothelium, we carried out static adhesion assays using
time-lapse video microscopy to observe the dynamics of
monocyte interactions with unactivated HUVECs under static
conditions. These experiments were performed in the ab-
sence of SDF-1 to establish if the endothelium plays a more
proactive role in regulating monocyte transmigration. Interac-
tions of adherent monocytes with HUVECs were analysed
and classified as adherent (phase light) or transmigrated
cells (phase dark) (18, 19). Even in the absence of SDF-1,
monocytes were observed to transmigrate under static con-
ditions confirming that unactivated HUVECs have an intrinsic
capability to support monocyte transmigration. Furthermore,
LPS-pre-treated monocytes were observed to remain adher-
ent to HUVEC monolayer surfaces and transmigrated at
much lower levels than non-treated monocytes (Fig. 3).
Therefore, LPS pre-treatment has rendered the monocytes
more adherent and unable to transmigrate through the
endothelium.
LPS pre-treatment of monocytes activates b2 integrins but
does not alter the level of expression
Integrins play an important role in the adhesion of leukocytes
to the endothelium (34). Interestingly, it has been shown that
adhesion induced by LPS is mediated at least in part by
LFA-1 (35, 36). To confirm a role for b2 integrins in our exper-
imental system, we carried out adhesion experiments using
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purified monocytes on recombinant ICAM-1 as a ligand for
LFA-1. Indeed, LPS pre-treatment induced increased adhe-
sion of monocytes to ICAM-1, and this was blocked by an
antibody against b2 integrins (Fig. 4a). However, this was
not a product of increased expression levels of aL or b2
integrins during LPS pre-treatment (Fig. 4b and c). Similarly,
expression levels of b1 integrins was unaffected by LPS pre-
treatment (Fig. 4d) in contrast to a recent study, showing
LPS-mediated up-regulation of b1 integrin (37). We then
postulated that increased monocyte adhesion was associ-
ated with a change in integrin activation on monocytes pre-
treated with LPS (38). To do this, we used mimetic mAbs
15/7 and mAb24 which recognize epitopes associated with
activation of b1 and b2 integrins, respectively (39, 40). Flow
cytometric analysis using these antibodies confirmed in-
creased activation of b1 integrin (Fig. 4e) and b2 integrin
(Fig. 4f) after LPS pre-treatment, which is consistent with in-
creased monocyte adhesion to HUVECs.
Fig. 1. LPS inhibits the transendothelial migration, increases the adhesive properties of monocytes but does not affect expression of chemokine
receptor CXCR4. (a) Pre-treatment of monocytes with LPS does not alter surface expression of chemokine receptor CXCR4 on monocytes. Flow
cytometric analysis of purified monocytes immunostained with mAb 12G5–PE confirmed CXCR4-surface expression levels were identical for
untreated (grey fill) and LPS-pre-treated monocytes (dotted line). Control monocytes were unlabelled (dotted line). (b) Transmigration of
monocytes and T cells. PBMCs were added to confluent monolayers of HUVECs grown in transwell culture inserts and incubated for 120 min in
the presence of human SDF-1 added to the lower chamber. PBMCs were pre-incubated with medium alone (grey bars) or LPS for 15 min
(1 lg ml1) (black bars). Transmigrated cells collected from the lower chamber were counted by light microscopy and total T cells or monocyte
counts were generated from flow cytometry using mAbs to CD3 and CD14, respectively. Asterisks indicate significance of P < 0.01 (**). The data
are representative of two independent experiments. (c and d) Adhesion of monocytes and T cells. PBMCs were pre-incubated in medium alone
(grey) or LPS (black) (at 1 lg ml1) for 15 min at 37C, and then added to confluent monolayers of HUVECs in 35 mm tissue culture dishes or six-
well plates. Following a 60-min incubation, the dishes were washed and the non-adherent cells were counted and stained for CD3 and CD14 to
determine the percentage of each cell type present. Data are presented as the mean number of (c) non-adherent monocytes (P < 0.001) or (d)
T cells calculated from triplicate dishes or wells. Error bars are SEM. Statistical analyses were performed using Student’s t-tests. The data are
representative of two independent experiments.
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Transendothelial migration of monocytes under physiological
flow is LPS independent
We have demonstrated that LPS pre-treatment blocks mono-
cyte transmigration across HUVECs under static conditions.
However, leukocyte interactions with the vascular wall in vivo
occur under flow, which induces a minimum shear stress of
0.05 Pa at the monocyte:endothelial interface. We therefore
decided to investigate monocyte interactions with endothe-
lium under flow conditions as observations made so far may
be linked to the use of static migration assays. Previous
studies have shown that physiological flow plays a critical
role in modulating transendothelial migration of lymphocytes
(41). We investigated if flow was sufficient to overcome the
increased adhesiveness and reduced transmigration of
LPS-pre-treated monocytes on activated endothelium. Flow
assays were carried out at a physiological flow rate
(0.05 Pa) on TNFa-activated HUVECs. Pre-treatment of LPS
did not affect the number of monocytes captured (data not
shown). We have shown that the capture of monocytes pre-
treated with and without LPS was mediated by b1 and b2
integrins, as blocking mAbs PS2 and TS1/18 reduced mono-
cyte adhesion (Fig. 5a) (42–45). In contrast to static transmi-
gration assays, LPS pre-treatment of monocytes had
no effect on transmigration with TNFa-activated HUVECs
(Fig. 5b). No adhesion or transmigration of monocytes was
observed with unactivated HUVECs, irrespective of LPS pre-
treatment (data not shown). Differences between activated
and unactivated HUVECs demonstrate that despite the
Fig. 2. The effect of LPS pre-treatment on monocyte adhesion and
transmigration on resting and activated endothelium. (a) Adhesion
and transmigration of monocytes. Purified monocytes, LPS treated
(black) or non-treated (grey), were incubated on HUVECs cultured
on transwell culture inserts for 120 min in the presence of human
SDF-1 added to the lower chamber. Non-adherent cells were
collected from the top chamber by gentle washing and counted by
light microscopy. The underside of the transwell was washed
gently with PBS and 2 mM EDTA and pooled with transmigrated
cells collected from the lower chamber and counted by light
microscopy. (b) LPS pre-treatment of monocytes increases accumu-
lation in the HUVEC monolayer. For each well, the sum of cells
collected from the top chamber (non-adherent) and the bottom
chamber (transmigrated) was subtracted from the total cells added.
Results are presented as the mean percentage of total cells added
from three separated transwells in a single experiment 6 SEM.
Statistical analyses were performed using Student’s t-tests comparing
groups marked by brackets. Asterisks indicate significance of P <
0.01(*) and P < 0.001 (**). The data are representative of two
independent experiments.
Fig. 3. Video analysis of LPS pre-treatment on monocyte trans-
migration under static conditions. Purified monocytes, LPS treated
(black) or non-treated (grey), were incubated and recorded by video
time-lapse microscopy on HUVEC monolayers for 30 or 120 min. Non-
adherent cells were removed by gentle washing and discarded.
Transmigration was assessed by counting monocytes that had
transmigrated (phase dark) or had not transmigrated (phase grey).
Transmigration was expressed as a percentage of the sum of total
monocytes per field (non-transmigrated cells plus transmigrated
cells). Results are presented as the mean percentage migration from
three separated fields filmed for 2 min in a single experiment at each
time point 6 SEM. Statistical analyses were performed using
Student’s t-tests comparing 6LPS at both time points.
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higher activation state of integrins on LPS-pre-treated mono-
cytes, transmigratory cues are required from activated endo-
thelium, and the application of shear stress alone on
unactivated endothelium is not sufficient. This is consistent
with a lack of selectin expression on unactivated HUVECs,
which is necessary for the initial tethering and rolling of leu-
kocytes onto the lumenal surface from free flow (46).
Investigating monocyte interactions with HUVECs under
decreasing flow conditions to near-stasis has helped to un-
derstand apparent inconsistencies and limitations in using
static assays. At flow rates of 0.025 Pa and below, higher
numbers of LPS-pre-treated monocytes adhered to the
unactivated HUVEC monolayer, which increased dramati-
cally as the flow rate was incrementally reduced (Fig. 6a). In
contrast, untreated monocytes remained largely non-
adherent with only a modest increase in the number of adherent
cells observed at the lowest flow rates tested. These mono-
cytes showed a gradual increase in transmigration >1 h with
LPS-pre-treated monocytes showing lower levels of transmi-
gration over this time period (Fig. 6b). This monocyte adhe-
sion was mediated by b1 and b2 integrins, as it was
dramatically reduced using blocking antibodies, with and
without LPS pre-treatment (Fig. 6c). To consolidate our
observations, monocytes that were allowed to adhere under
static conditions to HUVECs were exposed to augmented
flow rates. When flow was incrementally increased, mono-
cyte adhesion was gradually reduced with ;30% remaining
adherent even under very high flow rates (Fig. 7a). However,
LPS-pre-treated monocytes were more resistant to higher
shear stresses than non-treated cells. These monocytes
were still able to transmigrate with LPS-pre-treated cells
showing an ;40% reduction in transmigration compared
with non-treated cells (Fig. 7b).
Discussion
Sepsis is a contributing factor in up to 200 000 deaths per
year in the USA, and the incidence of sepsis continues to in-
crease worldwide due to increased frequency of invasive
procedures and widespread bacterial antibiotic resistance
(10). The mortality rate in patients with septic shock ranges
from 20 to 80%. Mortality is related to the severity of both
the sepsis and the underlying disorder that is invariably
present. The primary trigger in septic shock elicited by
gram-negative bacteria is endotoxin or LPS. Whereas LPS
itself is chemically inert, the presence of LPS in blood can
induce an overwhelming inflammatory response (10), leading
to a severe and rapid drop in blood pressure culminating in
multiple organ failure.
LPS interacts with CD14, which then complexes with TLR4
on the surface of monocytes and neutrophils (8). This inter-
action activates signal transduction pathways that in turn ac-
tivate integrins (47, 48). Integrin activation plays a critical
role in the multi-step adhesion cascade that describes the
passage of inflammatory cells from the blood into the tissue
at sites of inflammation (1). TLR4 is thought to engage LPS
through a common motif suggesting that any differential ef-
fect between bacterial strains, particularly under saturating
conditions, is unlikely (49, 50). Later studies have shown that
TLR2 can also recognize LPS from the bacteria Porphyromo-
nas gingivalis (33). Leukocyte recruitment during inflamma-
tion involves multiple adhesive interactions under shear
Fig. 4. LPS pre-treatment of monocytes activates b integrins and increases adhesion to ICAM-1, but does not affect integrin expression levels.
(a) Blocking monocyte adhesion by using an anti-b2 integrin antibody. LPS-pre-treated or untreated monocytes were incubated on immobilized
ICAM-1 in the presence of blocking antibodies to the integrin subunit b2 (TS1/18) or an isotype control. Non-adherent cells were removed by
washing and the remaining adherent cells stained with crystal violet. Results are presented as the mean of the OD at 570 nm of separate four
wells 6 SEM. Statistical analysis was performed using the Student’s t-test comparing groups 6TS 1/18 for LPS-treated monocytes. The data are
representative of two independent experiments. (b–d) Expression levels of integrins. Flow cytometric analysis investigating (b) aL, (c) b2 and (d)
b1 integrin subunit expression demonstrated that expression levels were identical for untreated (line) and LPS-pre-treated monocytes (dotted
line). (e and f) Activation state of integrins. Analysis by flow cytometry demonstrated an increased activation state of b1 and b2 integrins by
increased display of epitopes recognized by the mimetic mAbs (e) 15/7 and (f) mAb24 on monocytes pre-treated with LPS (line) compared with
untreated monocytes (dotted line). Isotype control profiles were contained in the first log of fluorescence (data not shown).
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stress. However, sepsis is characterized by drop in shear
stress at the vascular interface. This may prove a critical fac-
tor in leukocyte extravasation, as it has been shown that
transmigration of lymphocytes is increased by the applica-
tion of shear stress at the lymphocyte:endothelial interface
(41). This requires contact between lymphocytes and acti-
vated endothelium promoting a higher turnover of focal
adhesion sites consisting of integrins, thus facilitating
the lymphocyte movement through the endothelial barrier
(41). Observations made with neutrophils suggest that
shear stress plays a role in transmigration under restricted
endothelial inflammatory conditions (51). In particular, one
experimental model using neutrophils has shown that low-
level occupancy of b2 integrins can mediate increased
transmigration only under certain shear stress conditions. In
contrast, transmigration through chronically activated endo-
thelium expressing high levels of b2 integrin ligands and
E-selectin was shown to be shear independent. This model
is consistent with our observations using monocytes and
would imply that the activation of integrins on circulating leu-
kocytes by the presence of LPS in the vascular compartment
is a critical event in determining the pattern of leukocyte
transmigration during the different phases of sepsis.
In the scenario presented in this study, LPS stimulation of
circulating monocytes would lead to integrin activation and
entrapment on luminal surfaces. We have shown that mono-
cytes transmigrate under flow irrespective of LPS pre-
treatment. However, under static or sub-physiological flow
conditions, LPS activation leads to arrest of the monocyte
on the lumenal surface whereas non-activated monocytes
readily transmigrate across endothelium. This reflects the
critical nature shear wall stress plays by favouring more tran-
sient interactions, allowing adherent leukocytes to scan the
lumenal wall for further signals that promote transmigration.
The equivalent of near-static conditions may be reached dur-
ing septic shock, where there is a drastic reduction in blood
flow rate due to vasodilation and increased endothelial per-
meability. As far as we know, this is the first study to docu-
ment a decrease in monocyte transmigration under static
conditions following treatment of human monocytes with
LPS. Several other studies that look at the effects of LPS on
monocyte migration, which appear contradictory have been
published over the past decade. It has been shown that
LPS stimulation of endothelial cells induced increased leuko-
cyte transendothelial migration (52). Shen et al. (53) also ob-
served an increase in the migration of monocytes across
LPS-stimulated HUVECs, when LPS was present for the
duration of the experiment. The authors concluded that the
effect of LPS was primarily on the endothelial cell since pre-
treatment of monocytes with LPS had no effect on their
subsequent transmigration. However, we observed that
monocyte migration was inhibited after pre-treatment with
LPS when endothelium has not been exposed to LPS. These
discrepancies may not only be due to different experimental
conditions, but also the source of monocytes used. We have
used primary monocytes purified from freshly isolated blood,
whereas Shen et al. used differentiated HL-60 cells. Confir-
mation of increased monocyte adhesion was seen in another
study which demonstrated monocytes treated with LPS ad-
hered more firmly to HUVEC monolayers and serum-coated
plastic surfaces (27). Of particular interest was the finding
that LPS acted on the monocyte within 25 min to stimulate
adhesion to unactivated HUVECs. By contrast, to render the
endothelial cells more adhesive for untreated monocytes re-
quired 1.5–2 h pre-treatment of the HUVECs with LPS (27).
In accordance with these studies, our static experiments
have shown that LPS pre-treatment of monocytes increased
adhesion and this is parallelled by reduced transmigration.
However, LPS pre-treatment had no effect on monocyte
transmigration using activated endothelium under normal
physiological flow. Therefore, LPS stimulation may alter
Fig. 5. Adhesion and transmigration of LPS pre-treated monocytes
on activated HUVECs under flow. (a) Monocyte capture from flow by
activated HUVECs is mediated by b1 and b2 integrins. Monocytes pre-
treated with blocking mAbs to b1 integrins (PS2) and b2 integrin (TS1/
18) showed a significant decrease in capture from physiological flow.
Monocytes pre-treated with LPS showed a similar profile. Monocytes
were counted in three separate fields after bolus delivery (‘0’ min) and
presented as a mean 6 SEM. (b) LPS does not affect monocyte
transmigration under flow. Monocytes, LPS pre-treated (black) or
untreated (grey bars), were flowed over HUVEC monolayers. Trans-
migration was assessed at 0, 15 and 30 min. Transmigration is
calculated as a percentage of the sum of cells adhered to the surface
of the endothelium (phase light) and transmigrated cells (phase dark).
Results are presented as the mean of three independent experi-
ments6 SEM. No significant difference was seen between monocytes
pre-treated with LPS or untreated.
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monocyte migration predominantly in situations where blood
flow rate is reduced, such as during septic shock.
We have shown that activation of integrins on circulating
monocytes occurs rapidly upon exposure to LPS, whereas
endothelial cells require a number of hours to express gene
products, such as ICAM-1 and VCAM-1, that are known to
regulate transmigration of monocytes across the endothelial
barrier (54). The binding of LPS-pre-treated monocytes un-
der sub-physiological flow rates to the luminal wall may only
be relevant in the early stages of sepsis, as prolonged expo-
sure of endothelial cells to LPS within the vascular compart-
ment leads to activation of the endothelium. The binding of
activated circulating monocytes to the lumenal wall may rep-
resent a mechanism of how the vascular compartment can
permit the rapid exclusion of bacteria by phagocytosis,
exerted by the adhering monocytes on the lumenal surface
of blood vessels. Such a mechanism may represent an
event between bacteraemia, where low levels of bacteria
are present but blood pressure is normal and the patient
appears asymptomatic, and septicaemia, where the vascu-
lar compartment becomes overwhelmed with bacteria. How-
ever, if LPS exposure in vivo induces circulating monocytes
to become more adherent and accumulate on the vascular
wall in areas where normal shear forces are no longer oper-
ating, then this may contribute to their deleterious effects in
endotoxemia since they will release their battery of cytokines
directly into the bloodstream. It is important to note that un-
der normal blood flow and non-inflammatory conditions, the
higher shear rate at the lumenal wall will not permit attach-
ment of monocytes out of flow. This strategy of removing
bacteria from the vasculature by entrapment is also
employed by neutrophils. Activated neutrophils adherent to
vascular surfaces have been shown to release web-like
structures of DNA called neutrophil extracellular traps, which
actively ensnare bacteria in the circulation (55).
It is clear that the conditions of LPS pre-treatment used in
this study may not accurately reflect a concentration or time
of exposure of monocytes within the vascular compartment
during the early stages of sepsis in vivo. While many studies
have documented the levels of endotoxin and severity of
sepsis, it has proven difficult to extrapolate from quantitative
values of endotoxins measured clinically to the concentration
of LPS used in this study (56). The kinetics of bacterial clear-
ance during bacteraemia and sepsis is highly dependant on
many factors, such as bacteria type, host tolerance and re-
sponse, and the presence of other inflammatory stimuli
(56–58). This apparent heterogeneity in response is reflected
in many clinical studies that have documented the levels of
Fig. 6. At sub-physiological flow rates, monocytes pre-treated with
LPS show increased adhesion but reduced transmigration on
unactivated HUVECs. (a) Monocytes pre-treated with (black) or
without (grey) LPS were flowed over cultured unactivated HUVEC
monolayers at 0.05 Pa. Cells adhered after 5 min were counted in
three separate fields. The flow rate was then reduced in incremental
steps for 2 min and the cells counted as before. Adhesion is
represented as the mean of total cells per field 6 SEM. (b) Monocyte
transmigration on unactivated HUVECs >1 h. Transmigration is
determined by video recording a single field for 2 min and counting
both adherent and transmigrated cells. Time points were 15 min
(three fields counted starting at 12, 14 and 16 min after washout),
30 min (27, 29 and 31 min), 45 min (42, 44 and 46 min) and 60 min
(57, 59 and 61 min). Transmigration of monocytes is represented as
the mean percentage of total cells per field 6 SEM. (c) Monocyte
capture after decreased incremental flow is mediated by b1 and b2
integrins. Monocytes pre-treated with blocking mAbs to b1 (PS2) and
b2 integrin (TS1/18) showed a significant decrease in capture
compared with isotype controls on unactivated HUVECs during
reduced flow. Monocyte pre-treated with LPS showed a similar profile.
Monocytes were counted in three separate fields after flow was
reduced in 2-min incremental steps to 0.006 Pa and presented as
a mean6 SEM. Statistical analyses were performed using non-paired
Student’s t-tests comparing groups 6LPS at each time point.
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endotoxin in patients with sepsis where concentration ranges
recorded vary substantially (26, 56). The conditions of LPS
pre-treatment chosen in this study may therefore represent
an event that occurs in vivo during the early phase of a pro-
gressive bacterial infection in the vascular compartment.
While severe sepsis continues to be a major cause of
death, further investigation of this model in vivo with humans
may prove difficult, as this mechanism appears to play a role
in the early phase of sepsis, possibly when the patient is
showing little or no clinical symptoms. Therefore, further in-
vestigation is required in animal models of sepsis to fully elu-
cidate the kinetics of leukocyte trafficking in the early and
latter stages of septicaemia. Targeting monocyte migration
may prove to be a useful approach to the therapy of septic
shock, a syndrome that has so far proven extremely difficult
to treat.
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